非ICU住院COVID-19患者纵隔气肿的发生率与结局
这项回顾性观察研究在基于人群的三级COVID治疗中心纳入331例非ICU住院的重症至危重症COVID-19肺炎患者,全部完成临床评估和胸部CT并随访至出院或死亡。纵隔气肿(CT诊断纵隔组织内游离气体)发生48例,发生率14.5%(95%CI 10.9–18.8%)。CT严重度评分>15与纵隔气肿正相关(OR 4.09,p=0.002),无创通气也与纵隔气肿正相关(OR 4.46,p=0.005),但与气道压力无正相关。50例(15%)插管、88例(27%)死亡,纵隔气肿患者插管风险HR 3.72(p<0.001)、死亡风险HR 3.27(p<0.001)。
要点
- 非ICU住院的重症至危重症COVID-19肺炎患者中,纵隔气肿发生率为14.5%(95%CI 10.9–18.8%,48/331)。
- CT严重度评分>15与纵隔气肿正相关(OR 4.09,p=0.002),该评分>15者占35.2%(95%CI 26.2–44.9%)。
- 无创通气与纵隔气肿正相关(OR 4.46,p=0.005),但与气道压力无正相关。
- 纵隔气肿患者插管风险更高(HR 3.72,p<0.001),死亡风险更高(HR 3.27,p<0.001)。
- 总体50例(15%)插管、88例(27%)死亡。
适用人群与场景
- 纳入:诊断为COVID-19肺炎且病情为重症至危重症的住院患者。
- 排除:无呼吸衰竭的住院患者、观察不足24小时者、从ICU转入者。
- 场景:基于人群的单一机构三级COVID治疗中心的非ICU住院患者。
诊断标准与关键阈值
- 纵隔气肿定义:胸部CT扫描诊断的纵隔组织内游离气体。
- CT严重度评分>15为与纵隔气肿正相关的阈值(OR 4.09,p=0.002)。
研究设计与关键结果
- 研究类型:回顾性观察研究;基于人群的单一机构三级COVID治疗中心;331例非ICU住院重症至危重症COVID-19肺炎患者;无干预。
- 主要结果:纵隔气肿48/331例,发生率14.5%(95%CI 10.9–18.8%)。
- CT严重度评分>15与纵隔气肿正相关(OR 4.09,p=0.002),该评分>15者占35.2%(95%CI 26.2–44.9%)。
- 无创通气与纵隔气肿正相关(OR 4.46,p=0.005),但与气道压力无正相关。
- 50例(15%)插管,88例(27%)死亡。
- 纵隔气肿患者插管风险更高(HR 3.72,p<0.001),死亡风险更高(HR 3.27,p<0.001)。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现有助于界定非ICU环境下重症至危重症COVID-19肺炎中纵隔气肿的风险与结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Pneumomediastinum (PNM) is a rare complication of mechanical ventilation, but its reported occurrence in patients with acute respiratory distress syndrome secondary to COVID-19 is significant. The objective is to determine the incidence, risk factors, and outcome of PNM in non-ICU hospitalized patients with severe-to-critical COVID-19 pneumonia.
DESIGN: Retrospective observational study.
SETTING: Population-based, single-setting, tertiary-care level COVID treatment center.
PATIENTS: Individuals hospitalized with a diagnosis of COVID-19 pneumonia and severe to critical illness were included. Those hospitalized without respiratory failure, observed for less than 24 hours, or admitted from an ICU were excluded.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: All patients underwent a complete clinical assessment and chest CT scan, and were followed up from hospitalization to discharge or death. The outcome was the number of cases of PNM, defined as the presence of free air in the mediastinal tissues diagnosed by chest CT scan, in non-ICU hospitalized patients and the subsequent risk of intubation and mortality. PNM occurred in 48 out of 331 participants. The incidence was 14.5% (95% CI, 10.9-18.8%). A CT-Scan Severity score greater than 15 was positively associated with PNM (odds ratio [OR], 4.09; p = 0.002) and was observed in 35.2% of the participants (95% CI, 26.2-44.9%). Noninvasive ventilation was also positively associated with PNM (OR, 4.46; p = 0.005), but there was no positive association with airway pressures. Fifty patients (15%) were intubated, and 88 (27%) died. Both the risk for intubation and mortality were higher in patients with PNM, with a hazard ratio of 3.72 ( p < 0.001) and 3.27 ( p < 0.001), respectively.
CONCLUSIONS: Non-ICU hospitalized patients with COVID-19 have a high incidence of PNM, increasing the risk for intubation and mortality three- to four-fold, particularly in those with extensive lung damage. These findings help define the risk and outcome of PNM in severe-to-critical COVID-19 pneumonia in a non-ICU setting.
参考来源
- Muley M, Finamore P, Pedone C, et al. Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients. Crit Care Med. 2022. PMID: 36200776. doi:10.1097/CCM.0000000000005680
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。